Crohn’s Disease Market SWOT Analysis, Dynamics, Drivers, Key Indicators and Forecast to 2022-2030
Crohn’s Disease Market Highlights: The Crohn’s disease market is expected to reach USD 14.3 billion by 2030 at 3.7% CAGR during the forecast period 2022-2030. Crohn's disease is a type of inflammatory bowel disease (IBD), caused by a combination of environmental, immune, and bacterial factors in genetically prone individuals. There are no medications, drugs or surgical procedures that can cure or prevent Crohn's disease. It is expected that the disease affects about 3.2 per 1,000 people in Europe and North America. It is less common in Asia and Africa. Rates have, however, been growing, particularly in the developing world, since last few years. The Crohn’s & Colitis Foundation of America (CCFA) stated that over 1 million Americans were diagnosed with Crohn's & ulcerative colitis disorders and diseases, with maximum of them aged above 30. Increasing occurrence of Crohn's disease market has triggered a vigorous demand for its therapeutics. A survey conduct...